TELA Bio (TELA) Revenue (2018 - 2026)

TELA Bio's Revenue history runs 9 years deep, the most recent figure standing at $19.1 million for Q1 2026.

• On a quarterly basis, Revenue rose 2.91% year-over-year to $19.1 million in Q1 2026; TTM through Mar 2026 was $80.8 million, a 13.48% increase from a year earlier, with the FY2025 full-year figure at $80.3 million, up 15.84% from the prior year.
• Revenue slipped to $19.1 million in Q1 2026 per TELA's latest filing, from $20.9 million in the prior quarter.
• Across five years, Revenue topped out at $20.9 million in Q4 2025 and bottomed at $8.2 million in Q1 2022.
• The 5-year median for Revenue is $16.6 million (2024), against an average of $15.8 million.
• Across the five-year window, Revenue jumped 46.26% in 2023 and grew 2.91% in 2026, its largest moves.
• Year by year, Revenue stood at $11.6 million in 2022, then jumped by 46.26% to $17.0 million in 2023, then gained by 3.83% to $17.6 million in 2024, then rose by 18.24% to $20.9 million in 2025, then slipped by 8.67% to $19.1 million in 2026.
• Per Business Quant, the three latest TELA Revenue figures stand at $19.1 million (Q1 2026), $20.9 million (Q4 2025), and $20.7 million (Q3 2025).